Retrovirus Life Cycles
Viral Mutations
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 12, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Manu Aggarwal1, Vipul Periwal1
1National Institutes of Health, Bethesda, MD.
Forecasting drug resistance in human immunodeficiency virus (HIV) is crucial. A new model predicts viral evolution and identifies key mutations, suggesting Atazanavir (ATV) and Ritonavir (RTV) combination therapy is least resistant.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: